Abel Ayerza
![](http://upload.wikimedia.org/wikipedia/commons/thumb/c/c2/Abel_Ayerza.jpg/200px-Abel_Ayerza.jpg)
Abel Ayerza (21 May 1861 Buenos Aires, Argentina – 14 July 1918) was an Argentine doctor who gave his name to the cardiological condition Ayerza’s disease.[1]
Biography
[edit]Ayerza was the son of the Basque doctor, Toribio Ayerza. He was a fervent catholic, married to Adela Arning with whom he had 11 children. One of his sons was kidnapped and later killed by Juan Gallifi a local Sicilian gangster which caused a great public outcry.
He undertook his higher education in the Medical Faculty of Salvador College in 1872. In 1882 he was a visiting practitioner to the Hospital de Mujeres (Women’s Hospital) and in 1884 was an internal practitioner of the Hospital de Clínicas. In 1885 he completed his practical studies as an intern in this hospital where he presented his thesis titled “Clinical Observations” sponsored by Dr. Ignacio Pirovano. He achieved his doctorate with a Gold Medal in 1886.[1]
Two years later Ayerza travelled to Paris, France, to develop his technique of neurological examination and cardiopulmonary auscultation. Professor Jaccoud introduced him to nosology and Cartesian logical analysis at the Hôpital de la Pitié. He also worked with Jean Martin Charcot and Joseph Babinski at the Hôpital de la Sâltpetrière, with Pierre Carl Edouard Potain at the Hôpital de la Charité.
On his return to Buenos Aires in 1897 Ayerza acquired the position of First Chair of Clinical Medicine in the Medical Faculty of the University of Buenos Aires, the highest teaching level, where his particular educational style quickly found him renown.[1]
President of the Argentine Medical Association between 1900 and 1901. Counselor of the Faculty of Medical Sciences from 1906 to 1912. Full member of the National Academy of Medicine from 24 October 1914.
Author of more than 200 scientific publications, Abel Ayerza was the first Argentinian name to enter world medicine by dint of “Ayerza’s disease”
Ayerza’s disease
[edit]A syndrome of signs and symptoms which include sclerosis of the pulmonary artery, polycythemia, dyspnea and cyanosis. It was first described by Ayerza in a lecture in 1901. Later one of his students, Francisco C. Arrillaga, included the observations into a 1912 thesis and in 1925 published a full description of the disease.[2]
References
[edit]- ^ a b c Mazzei, J.A.; Mazzei, M.E. (Dec 2011), "A Tribute to Abel Ayerza", European Respiratory Review, 20 (122): 220–221, doi:10.1183/09059180.00006811, PMC 9487740, PMID 22130814, S2CID 2095865
- ^ "Ayerza's disease". Merriam Webster Medical. Merriam Webster Inc. Retrieved 17 Mar 2013.